Akihiro Sakashita

Akihiro Sakashita

Auto-generated profile, based on publicly available information

Akihiro Sakashita

Department of Palliative Medicine, Kobe University Graduate School of Medicine, Kobe, Japan

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2007 in European Journal of Pharmacology
Verified
Journal Article
Closed access
ASAkihiro Sakashita
Akihiro Sakashita
YNYoshihiro Nishimura
Yoshihiro Nishimura
TNTeruaki Nishiuma
Teruaki Nishiuma
KTKaori Takenaka
Kaori Takenaka
KKKazuyuki Kobayashi
Kazuyuki Kobayashi
MYMitsuhiro Yokoyama
Mitsuhiro Yokoyama

1 June 2006 in American Journal of Physiology-Lung Cellular and Molecular Physiology
Verified
Journal Article
Closed access
PDF file
KTKaori Takenaka
Kaori Takenaka
YNYoshihiro Nishimura
Yoshihiro Nishimura
TNTeruaki Nishiuma
Teruaki Nishiuma
ASAkihiro Sakashita
Akihiro Sakashita
TYTomoya Yamashita
Tomoya Yamashita
MYMitsuhiro Yokoyama
Mitsuhiro Yokoyama
Although mechanical ventilation (MV) is an important supportive strategy for patients with acute respiratory distress syndrome, MV itself can cause a type of acute lung damage termed ventilator-induced lung injury (VILI). Because nitric oxide (NO) has been reported to play roles in the pathogenesis of acute lung injury, the present study explores the effects on VILI of NO derived from chronically overexpressed endothelial nitric oxide synthase (eNOS). Anesthetized eNOS-transgenic (Tg) and wild-type (WT) C57BL/6 mice were ventilated at high or low tidal volume (Vt; 20 or 7 ml/kg, respectively) for 4 h. After MV, lung damage, including neutrophil infiltration, water leakage, and cytokine concentration in bronchoalveolar lavage fluid (BALF) and plasma, was evaluated. Some mice were given Nω-nitro-l-arginine methyl ester (l-NAME), a potent NOS inhibitor, via drinking water (1 mg/ml) for 1 wk before MV. Histological analysis revealed that high Vt ventilation caused severe VILI, whereas low Vt ventilation caused minimal VILI. Under high Vt conditions, neutrophil infiltration and lung water content were significantly attenuated in eNOS-Tg mice compared with WT animals. The concentrations of macrophage inflammatory protein-2 in BALF and plasma, as well as plasma tumor necrosis factor-α and monocyte chemoattractant protein-1, also were decreased in eNOS-Tg mice. l-NAME abrogated the beneficial effect of eNOS overexpression. In conclusion, chronic eNOS overexpression may protect the lung from VILI by inhibiting the production of inflammatory chemokines and cytokines that are associated with neutrophil infiltration into the air space.

1 September 2016 in Journal of Palliative Medicine
Verified
Journal Article
Closed access
TYTakashi Yamaguchi
Takashi Yamaguchi
SGSho Goya
Sho Goya
HKHiroyuki Kohara
Hiroyuki Kohara
HWHiroaki Watanabe
Hiroaki Watanabe
MMMasanori Mori
Masanori Mori
KTKeiko Tanaka
Keiko Tanaka
Background: Respiratory symptoms, dyspnea, cough, and death rattle, are common and distressing in advanced cancer patients. Palliation of respiratory symptoms is important to improve quality of life in cancer patients and their families/caregivers. Currently published clinical guidelines for the management of these respiratory symptoms in cancer patients did not cover the topics comprehensively or were not based on formal process for the development of clinical guidelines. Methods: The Japanese Society for Palliative Medicine (JSPM) decided to develop comprehensive clinical guidelines for the management of respiratory symptoms in cancer patients following the formal guideline developing process. Results: This article provides a summary of the recommendations with the rationales, as well as a short summary of the developing process, of the JSPM respiratory symptom management guidelines. We established 26 recommendations and all recommendations are based on the best available evidences and expert consensus. Discussion: More future clinical researches and continuous guideline updates are required to improve the quality of respiratory symptom management in cancer patients.

1 January 2018 in Circulation Journal
Verified
Journal Article
Closed access
PDF file
TKTakashi Kuragaichi
Takashi Kuragaichi
YKYuma Kurozumi
Yuma Kurozumi
SOShogo Ohishi
Shogo Ohishi
YSYasuo Sugano
Yasuo Sugano
ASAkihiro Sakashita
Akihiro Sakashita
YSYukihito Sato
Yukihito Sato
Background:Palliative care for heart failure (HF) patients is recommended in Western guidelines, so this study aimed to clarify the current status of palliative care for HF patients in Japan. Methods and Results:A survey was sent to all Japanese Circulation Society-authorized cardiology training hospitals (n=1,004) in August 2016. A total of 544 institutions (54%) returned the questionnaire. Of them, 527 (98%) answered that palliative care is necessary for patients with HF. A total of 227 (42%) institutions held a palliative care conference for patients with HF, and 79% of the institutions had <10 cases per year. Drug therapy as palliative care was administered at 403 (76%) institutions; morphine (87%) was most frequently used. Among sedatives, dexmedetomidine (33%) was administered more often than midazolam (29%) or propofol (20%). Regarding the timing of end-of-life care, most institutions (84%) reported having considered palliative care when a patient reached the terminal stage of HF. Most frequently, the reason for the decision at the terminal stage was “difficulty in discontinuing cardiotonics.” A major impediment to the delivery of palliative care was “difficulty predicting an accurate prognosis.” Conclusions:This large-scale survey showed the characteristics of palliative care for HF in Japan. The present findings may aid in the development of effective end-of-life care systems.


10 April 2017 in International Orthopaedics
Verified
Journal Article
Closed access
PDF file
SMShingo Miyazaki
Shingo Miyazaki
KKKenichiro Kakutani
Kenichiro Kakutani
YSYoshitada Sakai
Yoshitada Sakai
YEYasuo Ejima
Yasuo Ejima
KMKoichiro Maeno
Koichiro Maeno
KNKotaro Nishida
Kotaro Nishida